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Nostocarboline, a chlorinated and N-methylated carbolinium alkaloid, 
displays potent and selective inhibition of photoautotrophic organisms 
as well as the Malaria parasite Plasmodium falciparum, while showing 
very low toxicity to bacterial and fungal pathogens, rat myoblasts and 
crustaceans. New derivatives of nostocarboline incorporating Br, F or 
methyl substituents have been obtained through precursor-directed 
biosynthesis in Nostoc 78-12A (identical to Nostoc sp. ATCC 43238) 
by feeding this cyanobacterium with differently substituted tryptophan 
derivatives or 6-Br-norharmane (eudistomin N). These experiments 
substantiate the biosynthetic hypothesis and validate the inherent 
flexibility of the corresponding enzymes for metabolic engineering. 
The new derivatives inhibit the growth of the toxic bloom-forming 
cyanobacterium Microcystis aeruginosa PCC 7806 above 1 µM. The 
mode of action of nostocarboline was investigated using chlorophyll-a 
fluorescence imaging and it was demonstrated that a decrease in 
photosynthesis precedes cell death thus establishing the phytotoxic 
properties of this alkaloid. 
 
Introduction 
Cyanobacteria constitute a promising source for novel bioactive 
metabolites employing a structurally diverse chemical 
framework.
[1]
 These prokaryotic photoautotrophs face ecological 
pressure from both competing organisms and grazers and have 
thus evolved sophisticated chemical defense strategies through 
secondary metabolites. Whereas many depsipeptides and 
cyclopeptides have been identified as major bioactive 
compounds, 
[2]
 relatively few alkaloids have been described from 
cyanobacteria.
[3]
 We have recently isolated the carbolinium 
alkaloid nostocarboline from the freshwater cyanobacterium 
Nostoc 78-12A
[4]
 and found strong algicidal effects against 
competing eukaryotic and prokaryotic photosynthetic 
organisms.
[5]
 The allelochemical activity of this chlorinated 
carbolinium
[6]
 is thought to offer competitive advantage to the 
producing organism through selective inhibition of competitors 
populating the same habitats.
[7]
 
As recognized in recent years, such ecological implications of 
natural products can open up new avenues for potential 
therapeutic applications, if corresponding pathways in 
competitors or grazers and pathogens are targeted.
[8]
 In the 
context of research of our laboratories, these ecological 
implications of nostocarboline provided a chemical ecology 
rationale for the evaluation against the malaria parasite 
Plasmodium falciparium, as this parasite contains an organelle of 
photoautotrophic (cyanobacterial) origin, the apicoplast.
[9]
 
Nostocarboline was found to be active against P. falciparium in 
submicromolar concentration yet this was shown to be selective 
as little toxicity (IC50 > 100 !M against rat myoblasts) was 
determined.
[10]
 This potent and selective biological profile thus 
indicates that similar pathways in algae and Plasmodium might 
be targeted. Complementing this selective profile, nostocarboline 
was not determined active against a panel of pathogenic bacteria 
and fungi.
[5]
 These results substantiated the hypothesis that 
pathways unique to photoautotrophs and to Plasmodium, 
potentially through the apicoplast, are targeted by nostocarboline. 
This potent and selective profile of nostocarboline thus clearly 
warrants the evaluation of additional derivatives.  
Precursor-directed biosynthesis is a technology for the 
production of modified natural products in the producing organism 
itself.
[11]
 This strategy offers certain advantages when compared 
to combined approaches such as mutasynthesis or combinatorial 
biosynthesis,
[11]
 in that existing biosynthetic pathways in the 
native organisms can be exploited and no modification of the 
relevant enzymes is required. Moreover, questions about the 
biosynthesis of metabolites can be investigated and the 
promiscuity of enzymes for unnatural substrates can be probed. 
For cyanobacteria, relatively few studies documented the 
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successful implementation of precursor-directed strategies in vivo 
for the generation of novel natural product analogs.
[12]
 This might 
be due in part to the challenges associated with feeding 
potentially toxic precursors to prokaryotic photoautrotrophic 
organisms. In addition, some cyanobacteria such as Nostoc or 
Anabeana are able to carry out N fixation thus further decreasing 
their need for xenobiotic uptake. Lastly, the production of novel 
algicidal or phytotoxic compounds in a prokaryotic 
cyanobacterium constitutes a serious problem for the producer. In 
this study, we demonstrate that all these challenges can be 
successfully addressed, and that the bioproduction of novel 
algicidal nostocarboline derivatives can be carried out in Nostoc 
78-12A. Moreover, chlorophyll-a fluorescence imaging was used 
to investigate the mode of action of nostocarboline. 
Results and Discussion 
We postulate that the biosynthesis of nostocarboline follows 
the well-investigated route for !-carboline alkaloids (Scheme 
1).
[13]
 The halogenation of tryptophan proceeds likely via a 
tryptophan halogenase, which is well-precedented in the 
biosynthesis of halogenated indole alkaloids such as 
rebeccamycin
[14]
 and pyrroindomycin.
[15]
 Decarboxylation of 5-Cl-
tryptophan (2) would generate 5-Cl-tryptamine (3) that reacts with 
glyoxylic acid via a Pictet-Spengler type reaction to give the 
tetrahydro-!-carboline derivative 4.
[13, 16]
. Subsequent decarb-
oxylation and oxidation would generate the 6-Cl-!-carboline (5), 
which is proposed to be finally N-methylated to nostocarboline 
(6). We wanted to investigate two distinct processes of this 
proposed biosynthetic scheme, i.e. the final methylation and the 
possibility of employing different starting materials (derivatives of 
1 or 2) to carry analogs through the whole biosynthetic pathway. 
Scheme 1. Postulated biosynthesis of nostocarboline. 
At first, reference compounds (standards) as well as required 
precursors for feeding experiments needed to be synthesized. 
The brominated derivative 11 of nostocarboline as well as the 
precursor utilized for feeding were prepared starting from 
tryptamine 7 following literature procedures.
[17-20]
 1,2,3,4-
Tetrahydro-"-carboline 8 was obtained via a Pictet-Spengler 
reaction between 7 and glyoxylic acid followed by an acidic 
decarboxylation.
[17]
 Compound 8 was then oxidized with Pd/C to 
give norharmane 9 in high yield (98%).
[18, 19]
 Bromination of 9 with 
NBS afforded eudistomin N (10) in good yield (75%).
[20]
 Finally, 
the methylation of compound 10 to Br-nostocarboline (11) with 
CH3I was realized according to the procedure developed for the 
total synthesis of nostocarboline.
[4]
 
 
 Scheme 2. a) 1. H2O, HCl, r.t.; 2. KOH, 3. HCl, pH"4, r.t., 49%; b) Pd/C, p-
xylene, 98%; c) NBS, AcOH, 75%; d) MeI, i-PrOH, 40%. 
Having the required standards at hand, we wanted to 
investigate whether the enzyme mediating the putative terminal 
N-methylation step would recognize a different carboline 
substrate and if it would tolerate the larger Br substituent. 
Therefore, 6-Br-norharmane 10 (0.25 mM, final overall 
concentration, previously dissolved in DMSO) was added to 
BG11 medium, and inoculated with Nostoc 78-12A (identical to 
Nostoc sp. ATCC 43238).
[21]
 The culture was allowed to grow for 
four weeks in a 250 ml Erlenmeyer flask exposed to a 12h:12h 
light/dark cycle. The culture was harvested by lyophilization and 
the metabolites extracted with 60% EtOH. The extract was 
analyzed by HPLC-MS and the presence of 6-Br-nostocarboline 
(11) in the mixture was clearly identified upon comparison to the 
totally synthetic standard (Scheme 3). This result showed that 
feeding experiments with compounds similar to putative 
biosynthetic intermediates are possible in Nostoc 78-12A, 
corroborated the hypothesis that methylation of a halogenated 
carboline such as 10 is a biosynthetically viable operation, and 
demonstrated that the corresponding enzyme is tolerating a 
modified substrate. 
 
Scheme 3. Biotransformation of Br-carboline 10 to 11 mediated by Nostoc 78-
12A. 
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Encouraged by this result, we next tried to use different 
starter units, thus evaluating the promiscuity of all enzymes along 
the putative biosynthetic pathway towards substrate 
modifications. Thus, different tryptophan derivatives were first 
dissolved in DMSO and then diluted in BG11 medium to a final 
concentration of 0.25 mM before inoculation with with Nostoc 78-
12A in 500 ml Erlenmeyer flasks. The cultures were allowed to 
grow during four weeks exposed to a 12h:12 light/dark cycle, and 
then harvested and extracted with 60% EtOH. We could 
unequivocally demonstrate by HPLC-MS analysis and 
comparison to a synthetic standard that 5-Br-Trp was converted 
by Nostoc 78-12A to 6-Br-nostocarboline (11). In addition, a 
series of fluorinated Trp derivatives was transformed by Nostoc to 
the corresponding nostocarboline derivatives 17 and 18 (Scheme 
4). Interestingly, substitution on both positions 6 and 7 on the Trp 
indole ring was tolerated by the native enzymes along the 
biosynthetic pathway. This is noteworthy, as different steric and 
electronic consequences result from this substitution. Likewise, 
the 6-CH3-Trp and the 7-CH3-Trp were successfully employed, 
and the corresponding dehalogenated methylnostocarboline 
compounds 19 and 20 were isolated The compounds were 
purified by HPLC (characterized by 
1
H NMR and HiRes-MS) with 
isolation yields between 0.5 and 1.2 mg/L. Feeding experiments 
with electron-rich substrates such as 5-methoxy and 5-hydroxy-
Trp were less successful: In the case of the MeO-Trp, the 
corresponding nostocarboline derivative could be identified by 
HPLC but not isolated. Feeding of 5-hydroxy Trp was not 
possible, and the medium turned brown over a short amount of 
time. We also tried to utilize tryptamine derivatives, but it 
appeared that tryptamine was toxic for Nostoc 78-12A at the fed 
concentration (0.25mM), as chlorosis was induced within a short 
amount of time. 
Scheme 4. Conversion of different Trp derivatives by Nostoc 78-12A. 
Several interesting observations warrant further discussion. 
(1) Intermediates from the postulated pathway, such as for 
example the halogenated norharmane derivatives related to 5, 
could not be observed in any of the feeding experiments. This 
would likely be the case, if one of the involved enzymes would 
display lower tolerance for modification resulting in the buildup of 
a biosynthetic intermediate. (2) No chlorinated derivatives of 
compounds 18 and 20 could be observed, which suggests that 
the putative Trp halogenase does not accept halogenated or 
methylated tryptophan derivatives (at different positions on the 
ring) as substrates. This observation thus supports the hypothesis 
that the employed precursors enter the biosynthetic pathway en 
lieu of 2 (and not of 1). In contrast, nostocarboline itself was 
always observed, albeit in rather different concentrations with 
respect to the newly produced derivative. In the case of 
precursor-directed biosynthesis using Trp derivatives 
halogenated in the 5 position, the observed ratio was in favor of 
nostocarboline (Table 1), reaching ratios up to 5:1 in the case of 
5-F-Trp. This could be explained if the endogenously produced 5-
Cl-Trp is favored over the 5-F-Trp in either decarboxylation or 
Pictet-Spengler cyclization reactions. However, predicting relative 
rates and substrate preference in vivo without knowledge of 
substrate concentrations and purely based on product ratios is 
difficult. Nonetheless, it is interesting to point out that the 6-F-Trp 
precursor reverts the observed selectivity, and the new derivative 
18 is observed in excess. Comparing these two fluorinated 
substrates thus shows that the steric and electronic properties of 
6-F-Trp result in higher incorporation rates thus suggesting higher 
tolerance of the processing enzymes for 6-F-Trp when compared 
to 5-F-Trp and the endogenously produced substrate. The methyl 
substituted Trp precursors are incorporated in even higher ratios 
of 3:1 to 4:1 versus nostocarboline (6). 
 
The nostocarboline derivatives 11 and 17-20 were then evaluated 
for their inhibitory power to the growth of the toxic 
cyanobacterium Microcystis aeruginosa PCC7806. This species 
is a prototype of a bloom forming cyanobacterium of the genus 
Microcystis, which is involved in many harmful algal blooms 
throughout the world. The derivatives 11 and 17-20 were added 
to growing cultures on day 4 following established assays
[5]
 and 
the minimal inhibitory concentration was determined as the 
minimal concentration at which the growth rate of M. aeruginosa 
is decreased compared to controls. Whereas Br-nostocarboline 
matched the inhibitory power of nostocarboline (MIC = 1 µM), 
both the fluorinated and methylated derivatives 17-20 displayed 
lower activities, with the MIC values increased by one order of 
magnitude (Table 1). Inspection of the growth curves of 
Microcystis aeruginosa PCC 7806 before and after treatment with 
Br-nostocarboline 11 (Figure 1) demonstrated that addition of 1 
!M is sufficient to impact the growth of the toxic cyanobacterium, 
and concentrations above 50 !M induced cell death. This 
algicidal activity of Br-nostocarboline 11 was found comparable to 
the parent nostocarboline (6).
[5]
 
 
 
Table 1. Precursor directed biosynthesis starting from tryptophan derivatives 
Nr. R
1
 R
2
 #max Yield
[a]
 Ratio
[b]
 MIC
[c]
 
11 Br H 251, 306, 383 - 0.85 1 
17 F H 250, 302, 385 0.5 0.2 10 
18 H F 243, 307, 360; 1.2 1.3 10 
19 CH3 H 258, 309, 389 0.9 3.8 10 
20 H CH3 252, 314, 376 0.9 3.2 10 
 [a] Isolated yield in mg / L of culture suspension. [b] Ratio of produced 
derivative to nostocarboline as determined by HPLC. [c] Minimal inhibitory 
concentration in µM against M. aeruginosa PCC 7806. 
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Figure 1. Growth curves of Microcystis aeruginosa PCC 7806 before and after 
exposure to Br-nostocarboline 11. The compound was administered on day 4. 
OD refers to the optical density measured at 675 nm. 
 
Figure 2. Effects of nostocarboline on photosynthesis and cell death in 
higher plants a) Representative images of an infiltrated tobacco leaf at the 
beginning of the light-phase. At 0 hpi: Leaf areas infiltrated with 2% DMSO 
(control) or different concentrations of nostocarboline. Occurrence of necrotic 
lesions 24 and 48h after infiltration. b) Chlorophyll-a fluorescence imaging 
picture of the same leaf. c) Cell death at the infiltration site. Data are means ± 
SE of at least 3 individual plants at each time point. d) Representative images of 
an infiltrated tobacco leaf. At 24h after dark incubation: Marked leaf areas 
infiltrated with 2% DMSO (control) or 10 !M nostocarboline and occurrence of 
necrotic lesions after dark-plus-light combinations. 
After having established that the new derivatives 11 and 17-
20 display algicidal effects at concentrations similar or higher than 
nostocarboline (6), we wanted to investigate the mode of action of 
nostocarboline (6), and in particular as to whether the observed 
effects results from inhibition of photosynthesis.  In order to test 
the effects of nostocarboline (6) on photosynthesis, we used 
chlorophyll-a fluorescence imaging, a non-invasive technique for 
probing oxygenic photosynthesis.
[22]
 Necrotic lesions, which 
became visible about 12-24 h after infiltration of nostocarboline 
(6), occurred in tobacco leaves for concentrations #10 !M (Figure 
2a). Immediately after infiltration, the photosynthetic electron 
transport (PET) was inhibited, dependent upon the nostocarboline 
concentration used (Figure 2b). Cell death assays demonstrated 
that the down regulation of PET precedes cell death. In the first 
hours after nostocarboline treatment in the light, about 10% of all 
counted cells were found dead (Figure 2c), but photosynthesis 
was downregulated by about 50 % (10!M nostocarboline) (Figure 
2b).  
The occurrence of cell death after nostocarboline treatment is 
light dependent. On the one hand, significantly more dead cells 
were detected if the leaves had been exposed to light (Figure 2c). 
On the other hand, leaves which were put in the dark after 
nostocarboline infiltration showed no formation of necrotic 
lesions. But if exposed to light subsequently, necrotic lesions 
occurred (Figure 2d). This also indicates that the effect of 
nostocarboline is long-lasting (over days) in plant tissue.  
Preliminary experiments on the mechanism of photosynthesis 
inhibition as measured by P700 redox kinetics 
[23]
 indicate that the 
electron transport chain might be restricted upstream of 
photosystem I (PS I, data not shown). The effect of 
nostocarboline might be comparable to the non-selective 
herbicide paraquat (methylviologen, 1,1'-dimethyl-4,4'-
bipyridinium), which is a strong autooxidable electron acceptor in 
PS I; and its presence in light-exposed plants has several drastic 
consequences, like the production of superoxide.
[24]
 Similarly, 
downregulation of photosynthesis in the light after nostocarboline 
treatment could lead to an enhanced production of light-driven 
reactive oxygen species which could be responsible for the 
formation of the necrotic lesions.  
Conclusion 
In conclusion, we have shown that precursor-directed 
biosynthesis of algicidal and phytotoxic nostocarboline derivatives 
11 and 17-20 in the cyanobacterium Nostoc 78-12A is possible. 
Several implications concerning the biosynthetic hypothesis 
outlined in Scheme 1 became evident: (1) The N-methylation of a 
halogenated precursor is a biosynthetically viable transformation. 
(2) Whereas tryptophan derivatives can be employed, the 
corresponding tryptamine derivatives were not successful, 
suggesting a role for Trp in the biosynthesis of nostocarboline, (3) 
The enzymes along the biosynthetic pathway are promiscuous to 
the extent that other halogenated starter units (such as Br and F) 
as well as dehalogenated Me derivatives can be used. (4) 
Modified substrates such as 7-substituted Trp derivatives were 
not found to be halogenated thus suggesting reduced flexibility of 
the putative halogenase, and the precursors thus enter 
biosynthesis en lieu of 6-Cl-Trp 2. Studies on the mode of action 
of nostocarboline (6) using fluorescence imaging demonstrated 
that downregulation of photosynthesis preceded cell death and 
that its agency is light dependent. The present work thus delivers 
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new potential antiplasmodial agents and encourages the 
precursor-directed biosynthesis of other cyanobacterial 
metabolites of indole origin. 
Experimental Section 
Instruments and methods. BG11 was purchased from Sigma. NMR 
spectra were acquired on a Bruker AVII-800 equipped with a 
cryoprobe or a DPX-400 and the chemical shifts are referenced to 
residual solvent proton and carbon signals ($H 3.31, $c 49.0 for 
CD3OD; $H 2.50, $c 39.5 for DMSO-d6). Accurate mass ESI spectra 
were recorded on a MICROMASS (ESI) Q-TOF Ultima API. HPLC 
purification and analyses were performed on a Dionex HPLC system 
equipped with a P680 pump, an ASI-100 automated sample injector, 
a TCC-100 thermostated column compartment, a PDA-100 
photodiode array detector, a Foxy Jr. fraction collector and a MSQ-
ESI mass spectrometric detector. 
Synthesis. 
1, 2, 3, 4-tetrahydro-!-carboline 8.
[17]
 To a suspension of tryptamine 
(7) (10.0 g, 62.5 mmol, 1.0 eq.) in water (190 ml), glyoxylic acid 
monohydrate (6.33g, 68.8 mmol, 1.1 eq.) in water (15 ml) and a few 
drops of HCl (aq.) were added. The milky, light brown reaction 
mixture was stirred at rt for 15 min. A solution of KOH (3.40g, 60.6 
mmol, 0.96 eq.) in water (17 ml) was then slowly added and the pH 
was subsequently adjusted to pH~4 with HCl (aq.). The mixture was 
stirred at rt for 1 hour and then stored at 4°C for 12 hours. The 
resulting light brown solid was filtered and washed thoroughly with 
water. The solid was then suspended in water (160 ml) and 25% HCl 
(24ml, 0.60mmol) was slowly added. The mixture was heated to reflux 
for 30 minutes, 25% HCl (24ml, 0.60 mmol) was then added, the 
mixture was stirred at reflux for another 15 minutes before it was 
allowed to cool down to rt. The reaction mixture was stored at 4°C for 
3 days to allow for precipitation. The resulting solid was isolated by 
filtration and washed with water. The solid was then dissolved in 
water by heating to 55°C and the pH was adjusted to pH~12 with 20% 
KOH (aq.). The resulting white precipitate was filtered, washed with 
water and dried under reduced pressure to afford compound 8 as a 
colorless solid (5.22 g, 30.3 mmol, 49%). 
1
H NMR spectrum (400 
MHz, [D6] DMSO): $=10.62 ppm (s, 1H, NH), 7.34 ppm (d, 
3
J (H,H)= 
7.6 Hz , 1H), 7.25 ppm (d, 
3
J (H,H)=7.9 Hz, 1H), 7.00 ppm (m, 1H), 
6.92 ppm (m, 1H), 3.84 ppm (s, 2H), 3.32 ppm (s, 1H), 2.96 ppm (t, 
3
J 
(H,H)=5.7 Hz, 2H), 2.58 ppm (t, 
3
J (H,H)=5.6 Hz, 2H). HPLC-ESI-MS 
m/z [MH]
+
 173.3 (calcd for C11H13N2, 173.1) 
!-Carboline 9.
[18,19]
 To a suspension of 8 (5.11g, 29.7 mmol) in p-
xylene (150 ml) was added 3 spatulas of Pd/C (10%). The mixture 
was stirred at 145°C. The course of the reaction was monitored by 
HPLC-MS. After 24 hours the reaction was allowed to cooled down to 
rt and MeOH (300 ml) was added. The mixture was filtered through a 
pad of celite and the solvent was removed under reduced pressure to 
afford compound 9 as a white solid (4.86g, 28.9 mmol, 97%). 
1
H NMR 
spectrum (400 MHz, [D6] DMSO): $=11.55 ppm (s, 1H), 8.90 ppm (s, 
1H), 8.34 ppm (d, 
3
J (H,H)=5.4 Hz, 1H), 8.23 ppm (d, 
3
J (H,H)=8.0 Hz, 
1H), 8.09 ppm (d, 
3
J (H,H)=5.4 Hz, 1H), 7.60 ppm (d, 
3
J (H,H)=8.0 Hz, 
1H), 7.54 ppm (t, 
3
J (H,H)=8.1 Hz,  1H), 7.24 ppm (t, 
3
J (H,H)=8.0 Hz, 
1H). 
6-Br-!-carboline 10.
[20]
 To a solution of 9 (4.7g, 27.9 mmol, 1 eq.) in 
AcOH (180ml) was slowly added NBS (4.98g, 27.9 mmol, 1 eq.). The 
reaction mixture was stirred for 2 hours at rt before removing the 
solvent under reduced pressure. The residue was dissolved in CH2Cl2 
and sequentially washed with saturated solutions of NaHCO3, NaCl 
and Na2S2O3. The solution was dried (MgSO4) and the solvent was 
removed under reduced pressure. The compound was purified by 
flash chromatography on SiO2 (AcOEt, NEt3 0.1%) to afford a yellow 
solid (5.13 g, 20.8 mmol, 75%). Rf (AcOEt, NEt3 0.1%) 0.19; 
1
H NMR 
spectrum (400 MHz, CDCl3): $=8.93 ppm (s, 1H), 8.49 ppm (d, 
3
J 
(H,H)=5.4 Hz, 1H), 8.27 ppm (d, 
4
J (H,H)=1.9 Hz, 1H), 7.92 ppm (dd, 
3
J (H,H)=5.3 Hz, 
4
J (H,H)=1.1 Hz, 1H), 7.65 ppm (dd, 
3
J (H,H)=8.6 Hz, 
4
J (H,H)=1.9 Hz, 1H), 7.42 ppm (d, 
3
J (H,H)=8.6 Hz, 1H). 
6-Bromo-nostocarboline 11. MeI (50µl, 0.79 mmol, 2 eq.) was added 
at rt to a solution of 10 (0.097g, 0.39mmol, 1 eq.) in i-PrOH (2.5 ml). 
The solution was heated to reflux for 4 hours. The resulting yellow 
suspension was then cooled at rt and filtered. The filtrate was washed 
with i-PrOH and dried under reduced pressure to afford compound 11 
as a yellow solid (0.039 g, 0.15 mmol, 40%). UV (MeOH) #max (log%) 
209 (1.69), 251 (1.13), 306 (0.72), 383 (0.17); 
1
H NMR spectrum (400 
MHz, CD3OD): $=9.24 ppm (s, 1H, H-1), 8.69 ppm (d, 
3
J (H,H)=6.4 
Hz, 1H, H-4), 8.66 ppm (d, 
4
J (H,H)=1.7 Hz, 1H, H-5), 8.54 ppm (d, 
3
J 
(H,H)=6.4 Hz, 1H, H-3), 7.93 ppm (dd, 
3
J (H,H)=8.9 Hz, 
4
J (H,H)=1.7 
Hz, 1H, H-7) 7.73 ppm (d, 
3
J (H,H)=8.9 Hz, 1H, H-8), 4.54 ppm (s, 3H, 
N-Me); HRESI-QqTof-MS m/z [M]
+
 261.0028 (calcd for C12H10BrN2, 
261.0027) 
General procedure for the feeding experiments. Nostoc 78-12A 
(identical to Anabaena 78-12A and ATCC 43238) was cultured in 200 
ml of BG11 in a 500 ml Erlenmeyer flask at 22°C with a light/dark 
cycle of 12h:12h for 8 weeks. The precursors were dissolved in 
DMSO (1 ml) and sterilized by filtration prior to addition to the culture 
to obtain a final concentration of 0.25 mM. 
General procedure for the isolation of the metabolites. The 
lyophilized culture was extracted three times with aqueous EtOH 
(60%); the cell material was removed by centrifugation and the 
solvents were removed under reduced pressure. The resulting extract 
was dissolved in aqueous methanol (80%) and filtered (0.25µm). The 
metabolites were first identified by C18 RP-HPLC-UV-MS 
(Phenomenex Gemini C18 150 x 5 mm); Mobile phase A was 0.05% 
TFA in ACN and B was 0.05% TFA in water. The column was 
stabilized for 10min with 10% A, then a linear gradient was used to 
reach 100% A over 40min, followed by washing for 10min with 100% 
A. The flow rate was 1 mL / min. The compounds were purified by 
multiple runs of C18 RP-HPLC (Phenomenex Gemini C18 150 x 10 
mm). The column was stabilized for 10min with 10% A, the a linear 
gradient was used to reach 45% A in 15min, followed by washing for 
5 min with 100% A. The flow rate was 5 ml / min. The retention times 
are almost identical on both columns. The solvent was removed from 
the combined fractions with a stream of N2. The amount of sample 
was determined spectrophotometrically with the extinction coefficient 
of nostocarboline.
[4]
 The fermentation yield was calculated based on 
the volume of the culture and is given in Table 1, and the chemical 
yield is based on the amount of precursor emplyoed and is given 
below.  
6-Fluoro-nostocarboline 17. Retention time 8.4 minutes, 0.10 mg (1.0 
%); UV (MeOH) #max 250, 302, 385; 
1
H NMR spectrum (800 MHz, 
CD3OD): $=9.23 ppm (s, 1H, H-1), 8.68 ppm (d, 
3
J (H,H)=6.5 Hz, 1H, 
H-4), 8.50 ppm (d, 
3
J (H,H)=6.5 Hz, 1H, H-3), 8.17 ppm (dd, 
3
J 
(H,F)=8.4 Hz, 
4
J (H,H)=2.5 Hz, 1H, H-5), 7.80 ppm (dd, 
3
J (H,H)=8.9 
Hz, 
4
J (H,F)=4.0 Hz, 1H, H-8) 7.64 ppm (ddd, 
3
J (H,H)=8.9 Hz, 
3
J 
(H,F)=8.9 Hz, 
4
J (H,H)=2.5Hz, 1H, H-7), 4.54 ppm (s, 3H, N-Me); 
HRESI-QqTof-MS m/z [M]
+
 201.0840 (calcd for C12H10FN2, 201.0828) 
7-Fluoro-nostocarboline 18. Retention time 10.6 minutes, 0.24 mg 
(2.4 %); UV (MeOH) #max 243, 307, 360; 
1
H NMR spectrum (800 MHz, 
CD3OD): $=9.17 ppm (s, 1H, H-1), 8.63 ppm (d, 
3
J (H,H)=6.4 Hz, 1H, 
H-4), 8.51 ppm (d, 
3
J (H,H)=6.4 Hz, 1H, H-3), 8.46 ppm (dd, 
3
J 
(H,H)=9.0 Hz, 
4
J (H,F)= 5.2 Hz, 1H, H-5), 7.48 ppm (dd, 
3
J (H,F)=9.1 
Hz, 
4
J (H,H)= 2.1 Hz, 1H, H-8), 7.28 ppm (ddd, 
3
J (H,H)=9.0 Hz, 
3
J 
(H,F)=9.0 Hz, 
4
J (H,H)=2.1 Hz, 1H, H-6) 4.52 ppm (s, 3H, N-Me); 
HRESI-QqTof-MS m/z [M]
+
 201.0838 (calcd for C12H10FN2, 201.0828) 
6-Methyl-nostocarboline 19. Retention time 9.8 minutes, 0.18 mg (1.9 
%); UV (MeOH) #max 258, 309, 389; 
1
H NMR spectrum (800 MHz, 
CD3OD): $=9.16 ppm (s, 1H, H-1), 8.64 ppm (d, 
3
J (H,H)=6.4 Hz, 1H, 
H-4), 8.48 ppm (dd, 
3
J (H,H)=6.4 Hz, 
4
J (H,H)=1.0 Hz, 1H, H-3), 8.24 
ppm (br s, 1H, H-5), 7.70 ppm (m, 2H, H-7 and H-8), 4.53 ppm (s, 3H, 
 6 
N-Me), 2.04 ppm (s, 3H, Me); HRESI-QqTof-MS m/z [M]
+
 197.1071 
(calcd for C13H13N2, 197.1079) 
7-Methyl-nostocarboline 20. Retention time 10.1 minutes, 0.17 mg 
(1.7 %); UV (MeOH) #max 252, 314, 376; 
1
H NMR spectrum (800 MHz, 
CD3OD): $=9.10 ppm (br s, 1H, H-1), 8.58 ppm (d, 
3
J (H,H)=6.5 Hz, 
1H, H-4), 8.45 ppm (dd, 
3
J (H,H)=6.5 Hz, 
4
J (H,H)=1.0 Hz, 1H, H-3), 
8.28 ppm (d, 
3
J (H,H)=8.2 Hz, 1H, H-5), 7.34 ppm (br d, 
3
J (H,H)=8.2 
Hz, 1H, H-6), 7.34 ppm (br s, 1H, H-8), 4.50 ppm (s, 1H, N-Me), 2.01 
ppm (s, 1H, Me); HRESI-QqTof-MS m/z [M]
+
 197.1079 (calcd for 
C13H13N2, 197.1079) 
Biological evaluation 
Growth inhibition experiments against Microcystis aeruginosa PCC 
7806 were carried out as described in the literature.
[5]
 Effects of 
nostocarboline on higher plants were tested in tobacco (Nicotiana 
tabacum SNN) by infiltration of different concentrations in 6-8 weeks 
old leaves, exposed to a 14h:10h light/dark cycle, except as noted 
otherwise. Imaging of photosynthetic parameters from chlorophyll-a-
fluorescence were determined as described previously.
[22]
 Cell death 
studies were performed with 0.5 mg ml
-1
 propidium iodide. Cells with 
disrupted membranes allow propidium iodide to enter the cell and 
fluoresce, indicating cell death. The fluorescence is detected at 590 to 
650 nm after excitation at 488 nm using a cLSM (TCS SP2 with 
inverse DMIRB-microscope, Leica). 
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FULL PAPERS 
  Out of the green! Precursor-directed 
biosynthesis allowed for the 
production of new nostocarboline 
derivatives that display phototoxic and 
algicidal properties – in a phototrophic 
organism. The mechanism of action 
includes downregulation of photo-
synthesis, as demonstrated by 
chlorophyll-a fluorescence imaging. 
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